Position in INCY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$30,707,183
+$28,142,038 QoQ
Shares Held
270,882
+893.9% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#84
of 834 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KBC Group NV holds $308,329,117 across 107 Biotechnology names. INCY ranks #3 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
179,508 | $111,930,418 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
128,466 | $63,812,916 | |
| 3 | INCY |
Incyte Corp
This page
|
270,882 | $30,707,183 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
98,265 | $23,678,917 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
91,584 | $7,963,228 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
129,010 | $7,787,043 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
127,194 | $7,278,040 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
116,847 | $6,372,835 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,707,183 | 270,882 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $2,565,145 | 27,254 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $26,410,504 | 267,394 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $36,052,221 | 425,094 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $44,262,071 | 649,957 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $61,214,959 | 1,010,982 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $72,981,710 | 1,056,634 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $76,745,602 | 1,161,053 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $104,533,733 | 1,724,410 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $87,670,392 | 1,538,887 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $60,011,479 | 955,749 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $25,277,205 | 437,549 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $6,434,097 | 103,359 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $2,293,921 | 31,741 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $2,951,518 | 36,747 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $726,775 | 10,906 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $504,896 | 6,646 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $496,851 | 6,256 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $3,565,625 | 48,578 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $4,247,921 | 61,761 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $6,636,006 | 78,878 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $7,682,940 | 94,536 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $8,156,984 | 93,780 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $8,744,893 | 97,447 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $12,493,762 | 120,167 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $2,138,241 | 29,199 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||